MDRNA Repays $5.5M Loan to GE Capital | GenomeWeb

MDRNA this week announced that it has repaid all remaining debt on a $5.5 million loan from General Electric Capital, marking the RNAi drug shop's latest step toward overcoming its financial woes.

"The repayment of this loan removes all liens on our intellectual property, equipment, and other assets, thus providing us maximum flexibility in establishing broad target and therapeutic-based pharma collaborations," MDRNA President and CEO Michael French said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.